Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ying AW"'
Autor:
Yi Ying Aw
Publikováno v:
SSRN Electronic Journal.
Corporate governance is a significant part in a company. It is essential for a company to manage the business and affairs of company. The study attempts to determine corporate governance, the impact of company performance and risk of Mitsubishi Elect
Publikováno v:
Academy of Asian Business Review. 1:47-67
Autor:
Kin Choong Yow, Gui Ying Aw
Publikováno v:
Proceedings of the Fifth International ICST Conference on Heterogeneous Networking for Quality Reliability Security and Robustness.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Duplaquet L; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., So K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Biological and Biomedical Sciences Graduate Program, Harvard Medical School, Boston, MA 02115, USA., Ying AW; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Pal Choudhuri S; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Li X; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Xu GD; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Qiu X; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Li R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Singh S; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA., Wu XS; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY 11724, USA., Hamilton S; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Chien VD; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Liu Q; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Somerville TDD; Novartis BioMedical Research, Cambridge, MA 02139, USA., Heiling HM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Lee Y; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Zoller T; Novartis BioMedical Research, Cambridge, MA 02139, USA., Vakoc CR; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY 11724, USA., Doench JG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Forrester WC; Novartis BioMedical Research, Cambridge, MA 02139, USA., Abrams T; Novartis BioMedical Research, Cambridge, MA 02139, USA., Long HW; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Niederst MJ; Novartis BioMedical Research, Cambridge, MA 02139, USA., Drapkin BJ; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine and Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA., Kadoch C; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address: cigall_kadoch@dfci.harvard.edu., Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: matthew_oser@dfci.harvard.edu.
Publikováno v:
Cancer cell [Cancer Cell] 2024 Aug 12; Vol. 42 (8), pp. 1352-1369.e13. Date of Electronic Publication: 2024 Jul 18.
Autor:
Wei PL; Division of Colorectal Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.; Department of Surgery, College of Medicine, School of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Cancer Research Center and Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.; Graduate Institute of Cancer Biology and Drug Discovery, Taipei Medical University, Taipei 11031, Taiwan., Huang CY; School of Medicine, National Tsing Hua University, Hsinchu 30013, Taiwan.; Institute of Molecular and Cellular Biology, National Tsing Hua University, Hsinchu 30013, Taiwan.; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan., Chang TC; Department of Surgery, College of Medicine, School of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Division of Colon and Rectal, Department of Surgery, Shuang Ho Hospital, Taipei Medical University, Taipei 11031, Taiwan., Lin JC; Department of Radiotherapy and Oncology, Shuang Ho Hospital, Taipei Medical University, Taipei 11031, Taiwan., Lee CC; Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan., Prince GMSH; Department of Surgery, College of Medicine, School of Medicine, Taipei Medical University, Taipei 11031, Taiwan., Makondi PT; Kamuzu Central Hospital, National Cancer Center, Lilongwe P.O. Box 149, Malawi., Chui AW; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei 11031, Taiwan., Chang YJ; Cancer Research Center and Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan.; Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei 11696, Taiwan.; Graduate Institute of Clinical Medicines, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.; Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei 11031, Taiwan.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 11; Vol. 24 (12). Date of Electronic Publication: 2023 Jun 11.
Autor:
Balán IC; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA. ibalan@fsu.edu.; Department of Behavioral Science and Social Medicine, Florida State University College of Medicine, 2010 Levy Ave Building B Ste B0266, Tallahassee, FL, 32310, USA. ibalan@fsu.edu., Rios JL; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA., Lentz C; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA., Arumugam S; Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA., Dolezal C; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA., Kutner B; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA., Rael CT; HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY, USA., Ying AW; Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA., Macar OU; Department of Computer Science, Columbia University, New York, NY, 10027, USA., Sia SK; Department of Biomedical Engineering, Columbia University, New York, NY, 10027, USA.
Publikováno v:
AIDS and behavior [AIDS Behav] 2022 Jan; Vol. 26 (1), pp. 35-46. Date of Electronic Publication: 2021 May 26.
Autor:
Wang L; School of Public Health, University of Hong Kong, Hong Kong, China., Mai ZM; School of Public Health, University of Hong Kong, Hong Kong, China.; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States., Ngan RK; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, China., Ng WT; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, the University of Hong Kong, Hong Kong, China., Lin JH; School of Public Health, University of Hong Kong, Hong Kong, China.; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China., Kwong DL; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Chiang SC; School of Public Health, University of Hong Kong, Hong Kong, China.; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China., Yuen KT; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Princess Margaret Hospital, Hong Kong, China., Ng AW; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China., Ip DK; School of Public Health, University of Hong Kong, Hong Kong, China.; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China., Chan YH; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong, China., Lee AW; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Lung ML; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.; Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China., Ho SY; School of Public Health, University of Hong Kong, Hong Kong, China., Lam TH; School of Public Health, University of Hong Kong, Hong Kong, China.; Centre for Nasopharyngeal Carcinoma Research (CNPCR), Research Grants Council Area of Excellence Scheme, the University of Hong Kong, Hong Kong, China.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 Sep 27; Vol. 11, pp. 699241. Date of Electronic Publication: 2021 Sep 27 (Print Publication: 2021).
Autor:
Mai ZM; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China., Lin JH; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China., Ngan RK; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China., Kwong DL; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China., Ng WT; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China., Ng AW; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong SAR, China., Ip KM; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China., Chan YH; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China., Lee AW; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China., Ho SY; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China., Lung ML; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong SAR, China., Lam TH; School of Public Health, The University of Hong Kong, Hong Kong Special Administrative Region (SAR), China.; Centre for Nasopharyngeal Carcinoma Research, Research Grants Council Area of Excellence Scheme, The University of Hong Kong, Hong Kong SAR, China.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2020 Sep 12; Vol. 7 (10), pp. ofaa426. Date of Electronic Publication: 2020 Sep 12 (Print Publication: 2020).